hdac4 inhibitor lmk 235 Search Results


hdac4 5 inhibitors  (Selleck Chemicals)
93
Selleck Chemicals hdac4 5 inhibitors
A , Increased expression <t>of</t> <t>HDAC4/5</t> was achieved by adenovirus transduction (Ad.HDAC4 or Ad.HDAC5). B, Ad.HDAC4 or Ad.HDAC5 resulted in enhanced calcification that was inhibited with the treatment of leptomycin B (5nM) n=3 biological replicates in each group (with 2 representative replicates shown). Quantitative calcium assay in cells treated with C, Ad.HDAC4 and D , Ad.HDAC5 in the presence or absence of leptomycin demonstrated reduced calcification with leptomycin treatment. n=3 biological replicates in each group. E and F, Cytosolic and nuclear localization of HDAC4 and HDAC5 in AdHDAC4 and AdHDAC5 treated cells in the presence and absence of leptomycin (a nuclear export inhibitor, 10 nM for 3 hours) in osteogenic media. 12–13 cells in each group were used for analysis.
Hdac4 5 Inhibitors, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdac4+inhibitor+lmk+235/LMK-235/pmc12790707-38-12-16
Average 93 stars, based on 1 article reviews
hdac4 5 inhibitors - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
lmk235  (MedChemExpress)
95
MedChemExpress lmk235
Fig. 5. The protective effect of HGWWD against diabetic microvascular and endothelial dysfunc tion can be blocked by the inhibition of HDAC 4 activity. (A) The inhibitor of <t>HDAC4</t> <t>(LMK235,</t> a class II inhibitor targeting HDAC4) was used in the following experiments; (B) The reactive hyperemia time of hind limbs in mice treated with HGWWD (ig., 6 g/kg/day) and LMK235 (ip., 5 mg/kg/day) by laser speckle; (C) The analysis of the mean PU of hind limbs in mice. (D) Effects of HGWWD and LMK235 presented in the relaxation curve and (E) the value of maximal relaxation (Emax) and (F) pEC50 (the nega tive logarithm of EC50) of Ach; (G) The aortic HDAC4 activity in mice. Values are presented as mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, n = 10–16 samples from 5 to 8 mice/ group.
Lmk235, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hdac4+inhibitor+lmk+235/LMK-235/pm36764560-73-63-70
Average 95 stars, based on 1 article reviews
lmk235 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
hdac4 antibody - fitc conjugated (oaca02235)  (Aviva Systems)
N/A
Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional
   Buy from Supplier
hdac4 antibody (14h4l10), abfinity rabbit monoclonal  (Thermo Fisher)
N/A
HDAC4 Monoclonal Antibody for Western Blot
   Buy from Supplier

Image Search Results


A , Increased expression of HDAC4/5 was achieved by adenovirus transduction (Ad.HDAC4 or Ad.HDAC5). B, Ad.HDAC4 or Ad.HDAC5 resulted in enhanced calcification that was inhibited with the treatment of leptomycin B (5nM) n=3 biological replicates in each group (with 2 representative replicates shown). Quantitative calcium assay in cells treated with C, Ad.HDAC4 and D , Ad.HDAC5 in the presence or absence of leptomycin demonstrated reduced calcification with leptomycin treatment. n=3 biological replicates in each group. E and F, Cytosolic and nuclear localization of HDAC4 and HDAC5 in AdHDAC4 and AdHDAC5 treated cells in the presence and absence of leptomycin (a nuclear export inhibitor, 10 nM for 3 hours) in osteogenic media. 12–13 cells in each group were used for analysis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Article Title: Focal adhesion kinase promotes calcification of vascular smooth muscle cells via regulation of histone deacetylase 4 and 5

doi: 10.1161/ATVBAHA.123.319010

Figure Lengend Snippet: A , Increased expression of HDAC4/5 was achieved by adenovirus transduction (Ad.HDAC4 or Ad.HDAC5). B, Ad.HDAC4 or Ad.HDAC5 resulted in enhanced calcification that was inhibited with the treatment of leptomycin B (5nM) n=3 biological replicates in each group (with 2 representative replicates shown). Quantitative calcium assay in cells treated with C, Ad.HDAC4 and D , Ad.HDAC5 in the presence or absence of leptomycin demonstrated reduced calcification with leptomycin treatment. n=3 biological replicates in each group. E and F, Cytosolic and nuclear localization of HDAC4 and HDAC5 in AdHDAC4 and AdHDAC5 treated cells in the presence and absence of leptomycin (a nuclear export inhibitor, 10 nM for 3 hours) in osteogenic media. 12–13 cells in each group were used for analysis.

Article Snippet: To assess the effect of FAK inhibitors (VS-6063 #S7654, VS-4718 #S7653, Selleckchem), HDAC4/5 inhibitors (LMK-235 #S7569, Selleckchem), nucleus export inhibitor (Leptomycin B #9626, Cell Signaling Technology) on calcification, cells were treated with either drugs or vehicle control.

Techniques: Over Expression, Expressing, Transduction, Calcium Assay

Fig. 5. The protective effect of HGWWD against diabetic microvascular and endothelial dysfunc tion can be blocked by the inhibition of HDAC 4 activity. (A) The inhibitor of HDAC4 (LMK235, a class II inhibitor targeting HDAC4) was used in the following experiments; (B) The reactive hyperemia time of hind limbs in mice treated with HGWWD (ig., 6 g/kg/day) and LMK235 (ip., 5 mg/kg/day) by laser speckle; (C) The analysis of the mean PU of hind limbs in mice. (D) Effects of HGWWD and LMK235 presented in the relaxation curve and (E) the value of maximal relaxation (Emax) and (F) pEC50 (the nega tive logarithm of EC50) of Ach; (G) The aortic HDAC4 activity in mice. Values are presented as mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, n = 10–16 samples from 5 to 8 mice/ group.

Journal: Journal of ethnopharmacology

Article Title: The activation of histone deacetylases 4 prevented endothelial dysfunction: A crucial mechanism of HuangqiGuizhiWuwu Decoction in improving microcirculation dysfunction in diabetes.

doi: 10.1016/j.jep.2023.116240

Figure Lengend Snippet: Fig. 5. The protective effect of HGWWD against diabetic microvascular and endothelial dysfunc tion can be blocked by the inhibition of HDAC 4 activity. (A) The inhibitor of HDAC4 (LMK235, a class II inhibitor targeting HDAC4) was used in the following experiments; (B) The reactive hyperemia time of hind limbs in mice treated with HGWWD (ig., 6 g/kg/day) and LMK235 (ip., 5 mg/kg/day) by laser speckle; (C) The analysis of the mean PU of hind limbs in mice. (D) Effects of HGWWD and LMK235 presented in the relaxation curve and (E) the value of maximal relaxation (Emax) and (F) pEC50 (the nega tive logarithm of EC50) of Ach; (G) The aortic HDAC4 activity in mice. Values are presented as mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, n = 10–16 samples from 5 to 8 mice/ group.

Article Snippet: They include TSA (HDAC inhibitor, 1 mg/kg/day i. p., MedChemExpress, New Jersey, USA; catalog number: HY-15144), VB3 (SIRT inhibitor, 200 mg/kg/day i. p., MedChemExpress, New Jersey, USA; catalog number: HY-B0143), MS275 (HDAC I inhibitor, 10 mg/kg/ day i. p., MedChemExpress, New Jersey, USA; catalog number: HY12163), MC1568 (HDAC II inhibitor, 50 mg/kg/day i. p., MedChemExpress, New Jersey, USA; catalog number: No: HY-16914), or LMK235 (HDAC4 Inhibitor, 5 mg/kg/day i. p., MedChemExpress, New Jersey, USA; catalog number: HY-18998).

Techniques: Inhibition, Activity Assay